hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

  1. WIBRe001-A-43 (WIBR3_GBA1_IVS2_Het_10C2F)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  2. WIBRe001-A-44 (WIBR3_GBA1_IVS2_Het_10D11A)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  3. WIBRe001-A-49 (WIBR3_ATP13A2_FS_Homo_12_6)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  4. WIBRe001-A-50 (WIBR3_ATP13A2_FS_Homo_12_2)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  5. WIBRe001-A-51 (WIBR3_ATP13A2_FS_Homo_ 6_1)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  6. WIBRe001-A-52 (WIBR3_ATP13A2_FS_ 5_6)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  7. WIBRe001-A-53 (WIBR3_ATP13A2_FS_Homo_2_5)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  8. WIBRe001-A-54 (WIBR3_VPS13C_FS_Homo_E10-2)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  9. WIBRe001-A-58 (WIBR3_VPS13C_FS_Homo_H3-1)

    United States Albert Einstein College of Medicine (AECM)
    Disease:

    Parkinson disease

  10. WAe009-A-36 (JPH2-KO)

    China Anzhen Hospital (ANZHEN)
    Disease:

    Hypertrophic cardiomyopathy

  11. ASGRCi002-A (F3-3#1 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  12. ASGRCi003-A (F3-4#5 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  13. ATLABi008-A (AT-UC I Normal-iC06)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  14. ATLABi009-A (AT-UC I Normal-iC13)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal (average)

  15. BBANTWi012-A-1 (TTN_E48_V4623*)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Dilated cardiomyopathy

  16. BBANTWi012-A-2 (iPSC_FB_F19901C3_TTN_E48_L4612*)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Dilated cardiomyopathy

  17. BCHi007-A (HNDS0005-01 #B)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  18. BCHi009-A (HNDS0002-01 #D)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  19. BCHi009-A-1 (HNDS0002-01 #D CC26 +/+)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  20. BCHi011-A (HNDS0003-01 #F)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  21. BCHi011-A-1 (HNDS0003-01 #F CC39 +/+)

    United States Children's Hospital (BCH)
    Disease:

    Succinic semialdehyde dehydrogenase deficiency

  22. BCHi030-B (HNDS0131-01#I)

    United States Children's Hospital (BCH)
    Disease:

    Tuberous sclerosis complex

  23. BCHi047-A (HNDS0056-02#A)

    United States Children's Hospital (BCH)
    Disease:

    Phelan-mcdermid syndrome

  24. BCMi001-B (M22c8 and HSCC-003iPS-Sc8)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal (average)

  25. BCRTi002-A (P02-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  26. BCRTi007-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Polycystic kidney disease

  27. BIHi001-A-1 (iBCRT Cas9v1-3G-Kl.16)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (average)

  28. SIGi001-A-14 (SIGi001-A Bi-Allelic MAPT HA-tag)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  29. SIGi001-A-16 (SIGi001-A-9 Bi-Allelic MAPT HA-tag)

    Denmark Bioneer (BION)
    Disease:

    Frontotemporal dementia

  30. STBCi006-A-1 (ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  31. BIONi010-C-71 (BIONi010-C with an APOE 3/3 genotype with an additional, homozygous christchurch mutation)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  32. BIORTCi001-A (BAiPSC 000 and OSTiFGM2)

    Nigeria Biomedical Science Research and Training Centre (BIORTC)
    Disease:

    Normal (average)

  33. BUCREMi001-A (iPSC-S6D63H-1-hom)

    United States Boston University (BUCREM)
    Disease:

    Lethal brain and heart developmental defects

  34. WIBRe001-A-4 (WIBR3_PRKN_X3DEL_B1-3)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  35. WIBRe001-A-5 (WIBR3_PRKN_X3DEL_F2-5)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  36. WIBRe001-A-6 (WIBR3_PRKN_X3DEL_H2-2)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  37. WIBRe001-A-10 (WIBR3_FBXO7_FS_A3-1)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  38. WIBRe001-A-15 (WIBR3_DNAJC6_c.801-2 A>G+FS/c.801-2 A>G_G12-2)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  39. WIBRe001-A-16 (WIBR3_DNAJC6_FS/FS_H10-1)

    United States University of California, Berkeley (CAL)
    Disease:

    Parkinson disease

  40. CAMi014-A (A1ATD1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Alpha-1-antitrypsin deficiency

  41. CBDTi001-A

    India Institute for Stem Cell Science and Regenerative Medicine (CBDT)
    Disease:

    Normal (average)

  42. CBIGi001-A (AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Normal (average)

  43. CCMi001-A (DMD1)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Duchenne muscular dystrophy

  44. CHCMUi002-A

    China Children's hospital of Chongqing Medical University (CHCMU)
    Disease:

    Chronic granulomatous disease

  45. CHOCi005-A

    United States CHOC Children's (CHOC)
    Disease:

    Gm1 gangliosidosis

  46. WAe001-A-2I (H1 INS-PPImNG and CHOPe004-A-2I)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Normal (average)

  47. CHUVi001-A

    Switzerland Centre Hospitalier Universitaire Vaudois (CHUV)
    Disease:

    Normal (average)

  48. CIGLi001-A (RPChiPS8023G1, iPSC TBX4 WT, StemRNA™ Human iPSC 802-3G and SYNTHEGO 802-30F)

    United States Center for Infection and Genomics of the Lung (CIGL)
    Disease:

    Normal (average)

  49. CIRMi285-A (CW70022)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  50. CIRMi286-A (CW70028)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  51. CIRMi287-A (CW70029)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  52. CIRMi292-A (CW70035)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  53. CIRMi293-A (CW70036)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  54. CIRMi294-A (CW70037)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  55. CIRMi307-A (CW70052)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  56. CIRMi314-A (CW70064)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  57. CIRMi323-A (CW70085)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  58. CIRMi329-A (CW70091)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  59. CIRMi361-A (CW70129)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  60. CIRMi373-A (CW70143)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  61. CIRMi419-A (CW70208)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  62. CIRMi451-A (CW70254)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  63. CIRMi484-A (CW70296)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  64. CIRMi498-A (CW70313)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  65. CIRMi499-A (CW70314)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  66. CIRMi505-A (CW70320)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  67. CIRMi511-A (CW70326)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  68. CIRMi526-A (CW70350)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  69. CIRMi528-A (CW70353)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  70. CIRMi538-A (CW70369)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  71. CIRMi03Z-A (CW30461)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Dilated cardiomyopathy

  72. CMGANTi003-A (SEMD1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  73. CMGANTi004-A (SEMD2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  74. CMGANTi006-A (SEDC1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  75. CMGANTi007-A (SEDC2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  76. CMGANTi008-A (iPSC_MFS_FBN1_Fi930129_C8)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Marfan syndrome

  77. CRICKi003-A (iFCI002)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Intellectual disability

  78. CRICKi004-A (iFCI008)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  79. CRICKi005-A (iFCI004)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  80. CRICKi006-A (iFCI005)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  81. CRICKi007-A (iFCI009)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  82. CRICKi008-A (iFCI006 and NH13-0078)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    X-linked centronuclear myopathy

  83. CRICKi009-A (iFCI012 and iFCI012 CLONE 4)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  84. CRICKi010-A (iFCI013 and iFCI013 Clone 7)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  85. CRICKi011-A (iFCI016)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  86. CRICKi012-A (iFCI017)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  87. CRICKi013-A (iFCI018 Clone 6)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Von hippel-lindau disease tumor suppressor

  88. CRICKi014-A (iFCI019 Clone 4)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Von hippel-lindau disease tumor suppressor

  89. CRICKi015-A (iFCI020 Clone 1)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Von hippel-lindau disease tumor suppressor

  90. CRICKi016-A (iFCI021 Clone 7)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Lung cancer

  91. CRICKi017-A (iFCI022 Clone 4)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Lung cancer

  92. CRICKi018-A (iKER 12 and iFCI023)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Normal (average)

  93. CRICKi019-A (iKER 8 and iFCI024)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Normal (average)

  94. CRICKi020-A (iFCI025 and iKER 10)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Normal (average)

  95. CRICKi021-A (iFCI007)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Ullrich congenital muscular dystrophy

  96. CRICKi022-A (iFCI031)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Lung cancer

  97. CRICKi023-A (iFCI032)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Lung squamous cell carcinoma

  98. CRTDi001-A (T12.9 and C1-1)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (average)

  99. CSCIi001-A (niPSC HDF16 and niPSC-16.2b)

    United Kingdom Wellcome Trust - MRC Stem Cell Institute (CSCI)
    Disease:

    Normal (average)

  100. CSCIi002-A (niPSC HDF75 and niPSC-75.1c2)

    United Kingdom Wellcome Trust - MRC Stem Cell Institute (CSCI)
    Disease:

    Normal (average)

  101. CSSi001-A (Joub03cl2 and COR419)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  102. CSSi015-A (FC17)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal (average)

  103. CSUXHi003-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Waardenburg syndrome type 2

  104. CSUXHi004-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Waardenburg syndrome type 1

  105. CTEFi001-A (CTEF-hiPSC10 and FNUSA-hiPSC10)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal (average)

  106. DMBi001-A-2

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Normal (average)

  107. WAe009-A-58 (COL4A5 heterozygote)

    China Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (DZMH)
    Disease:

    Alport syndrome

  108. EDi010-A (RCi136)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  109. EDi010-B (RCi138)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  110. EDi011-A (RCi139)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  111. EDi011-B (RCi140)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  112. EDi011-C (RCi141)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  113. EDi018-B (RCi212)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  114. EDi018-C (RCi213)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  115. EDi046-A

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (average)

  116. EHTJUi002-A (DF-GMP-ZB11AR-H)

    China East Hospital Affiliated to Tongji University (EHTJU)
    Disease:

    Normal (average)

  117. EHTJUi004-A (DF-GMP-ZB12AN-I)

    China East Hospital Affiliated to Tongji University (EHTJU)
    Disease:

    Normal (average)

  118. ESi065-A ([IDDM1] FiPS 1.13-Ep6F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_type i diabetes mellitus

  119. ESi080-A (N1-FiPS4F#7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  120. ESi104-A (PMM2-CDG FiPS48-Sv4F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Pmm2-cdg

  121. ESi112-A

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  122. FDCHDPi001-A (FDCHDP01)

    China Fudan University (FDCHDP)
    Disease:

    Tourette syndrome

  123. FMMUNIi001-A (I-WT)

    Czech Republic Faculty of Medicine, Masaryk University (FMMUNI)
    Disease:

    Normal (average)

  124. FMMUNIi002-A (I-IF)

    Czech Republic Faculty of Medicine, Masaryk University (FMMUNI)
    Disease:

    Ventricular fibrillation

  125. FMMUNIi003-A (I-CPVT)

    Czech Republic Faculty of Medicine, Masaryk University (FMMUNI)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia

  126. GENEAe008-A (GENEA009 and SIVF09)

    Australia Genea (GENEA)

  127. GENEAe013-A (GENEA089)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  128. GENEAe014-A (GENEA029)

    United States Genea (GENEA)
    Disease:

    Normal (average)

  129. GENEAe015-A (GENEA020)

    United States Genea (GENEA)
    Disease:

    Huntington disease

  130. GENEAe017-A (GENEA023)

    Australia Genea (GENEA)
    Disease:

    Normal (average)

  131. GENEAe018-A (GENEA090)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  132. GENEAe019-A (GENEA091)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  133. GENYOi001-A (PBMC1-iPS4F1)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Normal (average)

  134. GENYOi003-A (PBMC2-iPS4F8)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Normal (average)

  135. GENYOi004-A (ASD-PBMC-iPS4F2)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Adnp syndrome

  136. GENYOi005-A (FPD/AML-PBMC-iPSC4F73)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Familial platelet disorder with associated myeloid malignancy

  137. WAe009-A-84

    China Guangxi Institute of Cardiovascular Diseases (GICD)
    Disease:

    Congenital heart disease

  138. WAe001-A-2C (SST-P2A-mCherry)

    China Guangzhou Laboratory (GL)
    Disease:

    Normal (average)

  139. GRCHJUi001-A (LYJ-iPS-C)

    China Guangzhou Red Cross Hospital of Jinan University (GRCHJU)
    Disease:

    Atrial fibrillation

  140. HCORDi001-I (M2_IPSC4_P)

    Brazil Hemocord Clínica Médica Ltda (HCORD)
    Disease:

    Normal (average)

  141. HEBHMUi010-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Normal (average)

  142. HELPi001-A (BS-TL-1)

    China Help Stem Cell Innovations Co.Ltd. (HELP)
    Disease:

    Congenital contractural arachnodactyly

  143. HHUi003-B (A4_C1)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Maternally-inherited leigh syndrome

  144. HHUi003-C (A4_W1)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Maternally-inherited leigh syndrome

  145. HHUi006-A (11656_H)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Normal (average)

  146. HHUi006-B (11656_K)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Normal (average)

  147. HNMUi009-A (iPS-UC1171)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  148. HVRDi005-A (BJ SiPS-D)

    United States Harvard University (HVRD)
    Disease:

    Normal (average)

  149. IBBISTi010-A (4_H17)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Hypertrophic cardiomyopathy

  150. IBBISTi011-A (3_H24)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Hypertrophic cardiomyopathy

  151. IBBISTi012-A (6_H35)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Hypertrophic cardiomyopathy

  152. IBBISTi013-A (4_H22)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Hypertrophic cardiomyopathy

  153. IBKMOLi003-A (vEDS COL3A1 Q105* iPSC)

    Austria University of Innsbruck, Institute of Molecular Biology (IBKMOL)
    Disease:

    Vascular ehlers-danlos syndrome

  154. IBKMOLi004-A (sCeAD iPSC)

    Austria University of Innsbruck, Institute of Molecular Biology (IBKMOL)

  155. IBKMOLi005-A (CTRL iPSC)

    Austria University of Innsbruck, Institute of Molecular Biology (IBKMOL)
    Disease:

    Normal (average)

  156. IBPi002-A (P71 iPSCs 1)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Prostate adenocarcinoma

  157. ICANi001-A (CDGEN1.16)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Hypertrophic cardiomyopathy

  158. ICANi001-A-1 (CDGEN1.16.40.5)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Hypertrophic cardiomyopathy

  159. ICANi002-A (ICAN-403.3)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Normal (average)

  160. ICANi002-A-1 (ICAN-FLNC42.1)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Normal (average)

  161. ICANi002-A-3 (ICAN-BAG3-V468MC34)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Dilated cardiomyopathy 1hh

  162. ICANi002-A-4 (ICAN_BAG3_M468MC19)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Dilated cardiomyopathy 1hh

  163. ICANi002-A-5 (ICAN-PKP2-H695-W11)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Arrhythmogenic right ventricular dysplasia 9

  164. ICGi002-A (DMD1_1)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  165. ICGi002-B (DMD1_4)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  166. ICGi002-C (DMD1_11)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  167. ICGi003-A (f3SMA3)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Spinal muscular atrophy type 3

  168. ICGi005-A (iSMA40)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  169. ICGi005-B (iSMA37)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  170. ICGi006-A (m3SMA13)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  171. ICGi006-B (m3SMA20)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  172. ICGi007-A (47Q-3Lf)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  173. ICGi009-A (iTAF3-17 and iTAF3del17)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  174. ICGi009-B (iTAF3del37 and iTAF3-37)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  175. ICGi013-A (iTAF13-26 and iTAF13del26)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  176. ICGi013-B (iTAF13del27 and iTAF13-27)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  177. ICGi015-B-1 (m6.7pCyto-17)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  178. ICGi018-A (iHD38Q-3)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  179. ICGi018-B (iHD38Q-2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  180. ICGi018-C (iHD38Q-1)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  181. ICGi019-A (HCM1f6)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  182. ICGi019-B (HCM1f33)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  183. ICGi021-A (K6-4f)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Normal (average)

  184. ICGi021-A-1 (K6-4fpCyto-13)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy

  185. ICGi022-A (K7-4Lf)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy subject

  186. ICGi025-A (iTAF11-4)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Developmental delay

  187. ICGi028-A (HCM4fm5.2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  188. ICGi029-A (HCM14fm6.2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  189. ICGi030-A (HF2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Wilson disease

  190. IDVi006-A (UBAP1L-3225)

    France INSTITUT DE LA VISION (IDV)
    Disease:

    Retinal dystrophy

  191. IGIBi002-A

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Beta-thalassemia

  192. IGIBi019-A (iPSC V2b)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  193. IGIBi020-A (iPSC V1b)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  194. IGIBi021-A (iPSC V3b)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  195. IGIBi022-A (iPSC V2c)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  196. IGIBi023-A (iPSC V1c)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  197. IGIBi024-A (iPSC V3c)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  198. IGIBi025-A (iPSC V3a)

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Normal (average)

  199. IMBPASi001-A (iPSC-WFS1-#1)

    Poland Institute of Medical Biology of Polish Academy of Sciences (IMBPAS)
    Disease:

    Wolfram syndrome 1

  200. IMGTi001-A (iTAF5-29)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
    Disease:

    Phelan-mcdermid syndrome

  201. INEUi004-A (FHL1-V)

    Argentina Instituto de Neurociencias Conicet (INEU)
    Disease:

    Muscular dystrophy

  202. INSAi003-A

    Portugal Instituto Nacional de Saude Ricardo Jorge (INSA)
    Disease:

    Mucolipidosis type ii

  203. INSRMi002-A (PC117_c2)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  204. INSRMi003-A (PC128_c5)

    France INSERM (INSRM)
    Disease:

    Normal (average)

  205. INSRMi004-A (PC118_c7)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  206. INSRMi005-A (PC119_c7)

    France INSERM (INSRM)
    Disease:

    Normal (average)

  207. INSRMi006-A (PC131_c8)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  208. INSRMi007-A (pc132-c4)

    France INSERM (INSRM)
    Disease:

    Normal (average)

  209. INSRMe002-A (STR-I-233-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  210. INSRMe003-A (STR-I-155-HD)

    France INSERM (INSRM)
    Disease:

    Huntington disease

  211. INSRMe004-A (STR-I-171-GLA)

    France INSERM (INSRM)
    Disease:

    Fabry disease

  212. INSRMe005-A (STR-I-189-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  213. INSRMe006-A (STR-I-209-MEN2a)

    France INSERM (INSRM)
    Disease:

    Endocrine gland cancer

  214. INSRMe007-A (STR-I-211-MEN2a)

    France INSERM (INSRM)
    Disease:

    Endocrine gland cancer

  215. INSRMe008-A (STR-I-203-CFTR)

    France INSERM (INSRM)
    Disease:

    Cystic fibrosis

  216. INSRMe009-A (STR-I-251-CFTR)

    France INSERM (INSRM)
    Disease:

    Cystic fibrosis

  217. INSRMe010-A (STR-I-221-Sca2)

    France INSERM (INSRM)
    Disease:

    Autosomal dominant cerebellar ataxia

  218. INSRMe011-A (STR-I-229-MTMX)

    France INSERM (INSRM)
    Disease:

    X-linked myopathy with excessive autophagy

  219. INSRMe012-A (STR-I-231-MTMX)

    France INSERM (INSRM)
    Disease:

    X-linked myopathy with excessive autophagy

  220. INSRMe013-A (STR-I-301-MFS)

    France INSERM (INSRM)
    Disease:

    Marfan syndrome

  221. INSRMe014-A (STR-I-305-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  222. INSRMe015-A (STR-I-315-CMT1a)

    France INSERM (INSRM)
    Disease:

    Charcot-marie-tooth disease type 1

  223. INSRMe016-A (STR-I-347-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  224. INSRMe017-A (STR-I-355-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  225. INSRMe018-A (STR-I-359-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  226. ITXi013-A (PT-R406W)

    France l’institut du thorax (ITX)
    Disease:

    Desminopathy

  227. JNCHi002-A (JNCHi002-A)

    China Jinan children's Hospital (JNCH)
    Disease:

    Familial hypercholesterolemia

  228. JTUi005-A

    China Sixth People's Hospital, Shanghai Jiao Tong University (JTU)
    Disease:

    Neuronal intranuclear inclusion disease

  229. KAIMRCi003-A (DRVT-iPSC#1)

    Saudi Arabia King Abdullah International Medical Research Center (KAIMRC)
    Disease:

    Dravet syndrome

  230. KAUSTi001-B (KS7-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  231. KAUSTi003-A (KS1-iPSC#D)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  232. KAUSTi004-A (HM-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  233. KAUSTi004-B (HM-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  234. KAUSTi005-A (HB-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  235. KAUSTi005-B (HB-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  236. KAUSTi005-C (HB-iPSC#C)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  237. KAUSTi006-A (KS6-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  238. KAUSTi006-B (KS6-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  239. KAUSTi007-A (KS2-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  240. KAUSTi007-B (KS2-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  241. KAUSTi008-A (KS4-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  242. KAUSTi008-B (KS4-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  243. KAUSTi008-C (KS4-iPSC#C)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  244. KAUSTi008-D (KS4-iPSC#D)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  245. KAUSTi008-E (KS4-iPSC#E)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  246. KAUSTi008-F (KS4-iPSC#F)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  247. KAUSTi008-G (KS4-iPSC#G)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  248. KAUSTi009-A (KS3-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  249. KAUSTi009-B (KS3-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  250. KAUSTi010-A (KS5-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  251. KAUSTi010-B (KS5-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  252. KAUSTi011-A (iPSC-GLP1R-KO-C1)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Developmental and epileptic encephalopathy

  253. KAUSTi011-B (iPSC-GLP1R-KO-H4)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Developmental and epileptic encephalopathy

  254. WAe001-A-I (H1.0-29/H1.1-13)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  255. WAe001-A-V (H1.1-39/H1.4-17)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  256. KCLi001-A (iOP118)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  257. KCLi002-A (iOP107)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  258. KCLi003-A (iOP101)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  259. KEIUi002-A (KOMENT-A)

    Japan Keio University (KEIU)
    Disease:

    Normal (average)

  260. KGUi001-A (AR1023)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Obsolete_bipolar disorder

  261. KGUi002-A (AR1034)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Obsolete_bipolar disorder

  262. KIe001-A-1

    Sweden Karolinska Institutet (KI)
    Disease:

    Normal (average)

  263. KIe053-A (HS983a)

    Sweden Karolinska Institutet (KI)
    Disease:

    Normal (average)

  264. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  265. KLRMMEi003-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Usher syndrome

  266. KRIBBi009-A (KRIBB-BC15)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal (average)

  267. WAe009-A-95 (hTRF1-KO #3)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal (average)

  268. WAe009-A-96 (hTRF1-KO #6)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    None

  269. KSCBi005-A (CMC-hiPSC-003)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (average)

  270. KSCBi006-A (KNIH-OI001i-A)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Osteogenesis imperfecta type 1

  271. BIONi010-C-56 (BIONi010-C-A713T-C25)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  272. BIONi010-C-57 (BIONi010-C-A713T-C42)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  273. BIONi010-C-58 (BIONi010-C-A713T-C1)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  274. BIONi010-C-59 (BIONi010-C-A713T-C33)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  275. BIONi010-C-60 (BIONi010-C-R589C-C7)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  276. BIONi010-C-61 (BIONi010-C-R589C-C16)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  277. BIONi010-C-62 (BIONi010-C-R589C-C5)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  278. BIONi010-C-63 (BIONi010-C-R589C-C9)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  279. KUi012-A-1 (JM09 GC)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  280. KUi013-A-1 (SK GC)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  281. KUMi001-A (KUMi001-A_CML(Ph+))

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Myeloid leukemia, philadelphia-positive

  282. KUMi002-A (CD34+ CML (Ph-) hiPSCs)

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Chronic myeloid leukemia

  283. KUMi004-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Chronic lymphocytic leukemia

  284. KUMi005-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Multiple myeloma

  285. KUMi006-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Multiple myeloma

  286. KUMCi001-A (ALLCD34+)

    South Korea KOREA UNIVERSTY COLLEGE OF MEDICINE (KUMC)
    Disease:

    Acute lymphoblastic leukemia

  287. KUMCi002-A (MM_CD34+iPSCs)

    South Korea KOREA UNIVERSTY COLLEGE OF MEDICINE (KUMC)
    Disease:

    Multiple myeloma

  288. LCPHi001-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Obsolete_parkinson's disease

  289. LCPHi003-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson disease

  290. LUMCi029-A (LUMC0072iCTRL01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  291. LUMCi029-B (LUMC0004iCTRL10)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  292. LUMCi039-A (LQT1-1781G/A hiPSC and LUMC0021iKCNQ-30)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Long qt syndrome 1

  293. LUMCi054-A (CRB1 patient c.3122T>C p.(Met1041Thr) homozygote and LUMC0116iCRB09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  294. LUMCi054-A-1 (LUMC0116iCRB09 ISO-02, LUMC0116iCRB09 homozygote CRISPR corrected isogenic clone 02 and iso02LUMC0116iCRB09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  295. LUMCi054-A-2 (LUMC0116iCRB09 ISO-03, LUMC0116iCRB09 heterozygote CRISPR corrected isogenic clone 03 and iso03LUMC0116iCRB09)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  296. LUMCi055-A (CRB1 patient 117 compound heterozygous 2983G>T p.(Glu995*) c.1892A>G, p.(Tyr631Cys) and LUMC0117iCRB01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  297. LUMCi056-A (CRB1 patient 128 compound heterozygous c.2843G>A p.(Cys948Tyr) and c.3122T>C p.(Met1041Thr) and LUMC0128iCRB01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  298. LUMCi056-A-1 (LUMC0128iCRB01 heterozygote CRISPR corrected isogenic clone 02 and iso02LUMC0128iCRB01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Retinitis pigmentosa

  299. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  300. MDCi008-A (8993-B12)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  301. MDCi009-A (8993-C11)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  302. MILi001-A (K10 and hFF-iPSCs)

    Germany Miltenyi Biotec B.V. & Co. KG (MIL)
    Disease:

    Normal (average)

  303. MILi001-B (F5)

    Germany Miltenyi Biotec B.V. & Co. KG (MIL)
    Disease:

    Normal (average)

  304. MILi001-C (F10)

    Germany Miltenyi Biotec B.V. & Co. KG (MIL)
    Disease:

    Normal (average)

  305. MLUi001-M

    Germany Medical Faculty of the Martin Luther University Halle-Wittenberg (MLU)
    Disease:

    Schizophrenia

  306. MLUi002-G

    Germany Medical Faculty of the Martin Luther University Halle-Wittenberg (MLU)
    Disease:

    Schizophrenia

  307. MMCi001-A (MMC-iPSC-052B-02)

    Taiwan Mackay Medical College (MMC)
    Disease:

    Deafness, autosomal recessive 1a

  308. MNZTASi034-A (MS_0034.1)

    Australia Menzies Institute for Medical Research (MNZTAS)
    Disease:

    Normal (average)

  309. MPIi002-A (T4 and L1-1Mut)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Obsolete_parkinson's disease

  310. MRIi018-A (HLHS_375)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Hypoplastic left heart syndrome

  311. MRIi024-A (Shox2.2)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Atrial fibrillation

  312. MSKi002-A (C27 and iPS-27)

    United States Memorial Sloan Kettering Cancer Center (MSK)
    Disease:

    Normal (average)

  313. WAe009-A-1J (H9::mcherry cyto-reporter line)

    United States Memorial Sloan Kettering Cancer Center (MSK)
    Disease:

    Normal (average)

  314. WAe009-A-1W (H9 EF1A-mCherry-noPuro 803_AAVS-iSHH #3)

    United States Memorial Sloan Kettering Cancer Center (MSK)
    Disease:

    Normal (average)

  315. MUi010-A (MYH9)

    Thailand Mahidol University (MU)
    Disease:

    Myh9-related disease

  316. MUi015-A (RB1)

    Thailand Mahidol University (MU)
    Disease:

    Retinoblastoma

  317. MUBi002-A (CF 001)

    Poland Medical University of Bialystok (MUB)
    Disease:

    Cystic fibrosis

  318. MURAi003-A (HoHLA, Homozygous-HLA and HoHLA C3)

    Thailand Faculty of Medicine Ramathibodi Hospital (MURA)
    Disease:

    Normal (average)

  319. MUSIi001-A-2 (HLA-I/II-null SFiPSCs)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Normal (average)

  320. MUSIi016-A (TyO)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Normal (average)

  321. NCHi003-A (NCH005)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Pulmonary valve atresia with intact ventricular septum

  322. NCHi006-A (NCH023)

    United States Nationwide Children's Hospital (NCH)

  323. NCHi013-A (NCH17)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Pulmonary valve atresia with intact ventricular septum

  324. NCHi014-A (NCH3-N1HET)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Normal (average)

  325. NCHi015-A (NCH178)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Type i truncus arteriosus

  326. NCHi023-A (NCH217)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Nemaline myopathy

  327. WAe001-A-65

    China Nanfang Hospital, Southern Medical University (NFYY)
    Disease:

    Epileptic encephalopathy

  328. NIHTVBi028-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Lyn gene mutation

  329. NIHTVBi029-A (HT1127A (NIHTVBi029-A))

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Cdc42

  330. NIHTVBi030-A (HT1128A (NIHTVBi030-A))

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Cdc42 gene

  331. NIHTVBi031-A (HT1129D)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Autoimmune interstitial lung, joint, and kidney disease

  332. TMOi001-A-5 (DISC1 Ex2 D5)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Normal (average)

  333. NMIi010-A

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Normal (average)

  334. NMIi011-A (B1.4)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  335. NMIi011-B (B1.6)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  336. NMIi011-C (B1.7)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  337. NMIi011-D (B1.10)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  338. NSi003-A (NSi-DS)

    India Stem Cell and Neurobiology Lab (NS)
    Disease:

    Down syndrome

  339. NSi003-B (NSi-isoEu)

    India Stem Cell and Neurobiology Lab (NS)
    Disease:

    Down syndrome

  340. NTUHi002-A

    Taiwan National Taiwan University Hospital (NTUH)
    Disease:

    Aceruloplasminemia

  341. NTUHi004-A

    Taiwan National Taiwan University Hospital (NTUH)
    Disease:

    Leigh syndrome

  342. NTUHi005-A (IBMS-iPSC-071-01)

    Taiwan National Taiwan University Hospital (NTUH)

  343. NUIGi001-A (iPSC ARO1-11)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autosomal recessive osteopetrosis

  344. OTATi001-A (HC4)

    United States Office of Tissues and Advanced Therapies, CBER, FDA (OTAT)
    Disease:

    Normal (average)

  345. PCIi029-A (PC076)

    France PHENOCELL (PCI)
    Disease:

    Waardenburg syndrome type 1

  346. PCIi030-A (PC078)

    France PHENOCELL (PCI)
    Disease:

    Waardenburg syndrome type 1

  347. PCIi031-A (PC079)

    France PHENOCELL (PCI)
    Disease:

    Waardenburg syndrome type 1

  348. PEIi021-A (PEIi004-A)

    Germany Paul-Ehrlich-Institut (PEI)
    Disease:

    Leukocyte adhesion deficiency type 1

  349. PEIi022-A (PEIi005-A)

    Germany Paul-Ehrlich-Institut (PEI)
    Disease:

    Leukocyte adhesion deficiency type 1

  350. PFIZi001-A (EM1-3F)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  351. RCi001-A (Thp3C-6 and RCi88)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  352. RCi001-B (RCi89 and Thp3C-9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  353. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  354. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  355. RCi003-A (RCi115 and CIP11A-5)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  356. RCi003-B (CIP11A-9 and RCi117)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  357. PNUSCRi001-A (GBA PD iPSC7)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson disease

  358. PNUSCRi002-A (GBA PD iPSC9)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson disease

  359. PNUSCRi003-A (GBA Gaucher iPSC1)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Gaucher disease

  360. PNUSCRi004-A (GBA PD iPSC8)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson disease

  361. PNUSCRi005-A

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Hunter syndrome

  362. WAe009-A-47

    China Peking University Third Hospital Department of Cardiology (PUHT)
    Disease:

    Cytochrome-c oxidase deficiency disease

  363. PUMCHi020-A

    China Peking Union Medical College Hospital (PUMCH)
    Disease:

    Aicardi-goutieres syndrome

  364. RCi004-A (PDSC-10 and RCi150)

    United Kingdom Roslin Cells (RC)
    Disease:

    Huntington disease

  365. RCe020-A (RC-16 and RC16)

    United Kingdom Roslin Cells (RC)
    Disease:

    Normal (average)

  366. RCMGi001-A (P1L5)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  367. RCMGi002-A (P7L2)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  368. RCMGi004-A (P6L2)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  369. RCMGi004-B (P6L8)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  370. RCMGi005-A (P5L1)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  371. RCMGi005-B (P5L5)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  372. RCMGi011-A (P10L1)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Mucopolysaccharidosis type ivb

    Disease:

    Autosomal recessive nonsyndromic deafness 12

  373. RCMGi015-A (P16L4)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Glycogen storage disease i

  374. RCMGi016-A (P17L16)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Glycogen storage disease i

  375. RCPCMi003-A (ATXN1KCl2)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Spinocerebellar ataxia type 1

  376. RCPCMi004-A (Park14-4)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Obsolete_parkinson's disease

  377. RCPCMi005-A (IPSP12-1)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Obsolete_parkinson's disease

  378. RCPCMi007-A (IPSFF1S)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Normal (average)

  379. RCPCMi008-A (IPS SCA17 sev cln4)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Spinocerebellar ataxia type 17

  380. RCPCMi009-A (IPSRG4S and UEF-3B)

    Finland Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Normal (average)

  381. RCPCMi010-A (iPS 67-7)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    X-linked intellectual disability, nascimento type

  382. RCSIi001-A (iPDK)

    Ireland Royal College of Surgeons in Ireland (RCSI)
    Disease:

    Normal (average)

  383. REGUi001-A (IPS4FLV)

    France Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
    Disease:

    Normal (average)

  384. REGUi009-A (myasthenic syndrome due to mutation in ColQ and hiPS 5-9016)

    France Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
    Disease:

    Congenital myasthenic syndrome

  385. RGIe049-A (SI-137)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  386. RGIe050-A (SI-138)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  387. RGIe051-A (SI-139)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  388. RGIe052-A (SI-140)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  389. RGIe053-A (SI-141)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis type 1

  390. RGIe134-A (SI-235)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  391. RIi005-A (TYR.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Tyrosinemia type 1

  392. KUIFMSi004-A-1 (hPSC MPP8 Neon Green)

    Russia Pirogov Russian National Research Medical University (RNRMU)
    Disease:

    Normal (average)

  393. RUESe001-A (RUES1)

    United States The Rockefeller University (RUES)
    Disease:

    Normal (average)

  394. RUESe002-A-6 (RUES2-GLR)

    United States The Rockefeller University (RUES)
    Disease:

    Normal (average)

  395. SAPi002-A (ALS I, ALS I–FUS-R514S/wt and FUS-R514S/wt)

    Italy Sapienza University of Rome (SAP)
    Disease:

    Amyotrophic lateral sclerosis

  396. SAPi003-A (ALS II, FUS-R521C/wt and ALS II–FUS-R521C/wt)

    Italy Sapienza University of Rome (SAP)
    Disease:

    Amyotrophic lateral sclerosis

  397. SAPi004-A (ALS III, TDP43-A382T/A382T and ALS III-TDP43-A382T/A382T)

    Italy Sapienza University of Rome (SAP)
    Disease:

    Amyotrophic lateral sclerosis

  398. SBWCHi001-A

    China Shenzhen Baoan Women's and Children's Hospital, Jinan University (SBWCH)
    Disease:

    Ctnnb1 gene mutation

  399. SCAUi001-A

    China South China Agricultural University (SCAU)
    Disease:

    Normal (average)

  400. SCHi001-A-1 (AMN5-Corrected iPSC)

    South Korea Severance Children’s Hospital (SCH)
    Disease:

    Adrenoleukodystrophy

  401. SCVIi051-A (477)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  402. SCVIi053-A (2021)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  403. SCVIi073-A (SCVIi574C2)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  404. SCVIi128-A (SCVI766)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Marfan syndrome

  405. SCVIi129-A (SCVI2454)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Marfan syndrome

  406. SDQLCHi061-A

    China Children’s Hospital affiliated to Shandong University (SDQLCH)
    Disease:

    Carbamoyl phosphate synthetase i deficiency disease

  407. SDQLCHi067-A

    China Children’s Hospital affiliated to Shandong University (SDQLCH)
    Disease:

    Subcortical band heterotopia

  408. SDQLCHi068-A

    China Children’s Hospital affiliated to Shandong University (SDQLCH)
    Disease:

    Immunodeficiency 14a, autosomal dominant

  409. SDUe001-A (Odense3)

    Denmark University of Southern Denmark (SDU)

  410. SHEHi002-A (iPS36)

    China Shanghai East Hospital (SHEH)
    Disease:

    Long qt syndrome 8

  411. SMBCi011-A

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Prader-willi syndrome

  412. SMUSHi002-A

    China Southern Medical University Shenzhen hospital (SMUSH)
    Disease:

    Normal (average)

  413. SNUe007-A (SNUhES31)

    South Korea Seoul National University (SNU)
    Disease:

    Normal (average)

  414. UOSe012-A-1

    United Kingdom University of Southampton (SOTON)
    Disease:

    Normal (average)

  415. SPHi001-A (SLEi002HZY)

    China Shenzhen People's Hospital (SPH)
    Disease:

    Systemic lupus erythematosus

  416. WAe009-A-48

    China Shenzhen People's Hospital (SPH)
    Disease:

    Long qt syndrome 3

  417. WAe009-A-74

    China Shenzhen People's Hospital (SPH)
    Disease:

    Long qt syndrome 2

  418. WAe009-A-88

    China Shenzhen People's Hospital (SPH)
    Disease:

    Long qt syndrome 2

  419. SPPHIi003-A

    China Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital (SPPHI)

  420. SUSMi005-A

    United States Stanford University School of Medicine (SUSM)
    Disease:

    Obsolete_parkinson's disease

  421. WAe001-A-81

    China The Seventh Affiliated Hospital (SYSUSH)
    Disease:

    Normal (average)

  422. SZBKi003-A

    China Shenzhen Beike Biotechnology Co., Ltd. (SZBK)
    Disease:

    Normal (average)

  423. SZGJMSi001-A (ZLP-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Schizophrenia

  424. SZGJMSi002-A (TSQ-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Obsessive-compulsive disorder

  425. SZGJMSi003-A (TSH-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Normal (average)

  426. SZGJMSi004-A (WJM-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Depression

  427. TCIERi001-A (IER-EK1)

    Taiwan Institute of Eye Research, Hualien Tzu Chi Hospital (TCIER)
    Disease:

    Normal (average)

  428. TMPi014-A (MR030 c1 and MR-030 c1)

    Switzerland Translational Molecular Psychiatry (TMP)
    Disease:

    Attention deficit hyperactivity disorder

  429. TNRMCi001-A (iTAF32)

    Russia Tomsk National Research Medical Center of the Russian Academy of Sciences (TNRMC)
    Disease:

    Cystic fibrosis

  430. TRNDi042-A (HT528A)

    United States NIH/NCATS-TRND Branch (TRND)
    Disease:

    Mucopolysaccharidosis type iiib

  431. TUSMi001-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal (average)

  432. TUSMi002-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal (average)

  433. TUSMi003-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  434. TUSMi004-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsessive-compulsive disorder

  435. TUSMi005-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsolete_bipolar disorder

  436. UCLi005-A (LGMD2D Pt. 4 and LGMD2D #4)

    United Kingdom University College London (UCL)
    Disease:

    Limb-girdle muscular dystrophy

  437. UCLi024-A (SMID277 and GOS111B)

    United Kingdom University College London (UCL)
    Disease:

    Argininosuccinic aciduria

  438. WAe001-A-10 (H1_RB1ex3_G3)

    Germany Universität Duisburg-Essen (UDE)
    Disease:

    Retinoblastoma

  439. UGOTSAi002-B (N1-001iC2)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  440. UGOTSAi003-A (N1-002iC3A)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  441. UGOTSAi003-B (N1-002iC4)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  442. UGOTSAi004-A (N1-003iC3)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  443. UGOTSAi004-B (N1-003iC4)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  444. UGOTSAi005-A (N1-004iC2)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Normal (average)

  445. UGOTSAi005-B (N1-004iC6)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Normal (average)

  446. UGOTSAi006-A (N1-005iC1)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  447. UHi006-A-3 (HEL24.3_IFIH1KO)

    Finland University of Helsinki (UH)
    Disease:

    Type i diabetes mellitus

  448. UIOi001-A (AG27)

    Norway University of Oslo (UIO)
    Disease:

    Normal (average)

  449. UIOi006-A (iPSC APOE4/4: Sporadic AD (Coriell #AG10788, female, Age 87))

    Norway University of Oslo (UIO)

  450. UJSi001-A

    China Jiangsu University (UJS)
    Disease:

    Schizophrenia

  451. UKAi010-A (BM 104-12)

    Germany Universitätsklinikum Aachen (UKA)
    Disease:

    Normal (average)

  452. UKEi001-A (ERC001sv1162)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  453. UKEi001-A-1 (CRYABhom)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Desminopathy

  454. UKEi001-B (ERC001sv1352)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  455. UKEi001-C (ERC001sv1355)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  456. UKEi002-A (ERC017sv2575)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  457. UKEi002-C (ERC017sv2596)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  458. UKEi003-A (ERC018sv1583)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  459. UKEi003-B (ERC018sv1590)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  460. UKEi003-C (ERC018sv1634)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal (average)

  461. HVRDe006-A-1

    United States Universitätsklinikum Erlangen (UKER)
    Disease:

    Coffin-siris syndrome

  462. UKJi001-A (PKP2-hiPSC)

    Germany Universitätsklinikum Jena (UKJ), Klinik für Innere Medizin I (KIM I), Dr. M. Bekhite ELsaied (UKJ)
    Disease:

    Normal (average)

  463. UKJi003-A (hiPSC-FD)

    Germany Universitätsklinikum Jena (UKJ), Klinik für Innere Medizin I (KIM I), Dr. M. Bekhite ELsaied (UKJ)
    Disease:

    Fabry disease

  464. UKJi004-A (hiPSC-WT)

    Germany Universitätsklinikum Jena (UKJ), Klinik für Innere Medizin I (KIM I), Dr. M. Bekhite ELsaied (UKJ)
    Disease:

    Normal (average)

  465. UKJi006-A (PKP2-hiPSC-ARVC)

    Germany Universitätsklinikum Jena (UKJ), Klinik für Innere Medizin I (KIM I), Dr. M. Bekhite ELsaied (UKJ)
    Disease:

    Arrhythmogenic right ventricular cardiomyopathy

  466. UKKi035-B (NP0139-B and NP0139-6C)

    Germany Klinikum der Universität zu Köln (UKK)
    Disease:

    Rare hypertrophic cardiomyopathy

  467. UMILi024-A (CTL04)

    Italy University of Milan (UMIL)
    Disease:

    Normal (average)

  468. WAe009-A-37 (H9-GSX2-tTA:GFP)

    Italy University of Milan (UMIL)
    Disease:

    Normal (average)

  469. UNAMi002-A (IFC-UNAM iPD02-S)

    Mexico Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM)
    Disease:

    Parkinson disease

  470. UNAMi003-A (IFC-UNAM iPD03-PINK1)

    Mexico Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM)
    Disease:

    Parkinson disease

  471. UNIPDi004-A

    Italy University of Padova (UNIPD)
    Disease:

    Normal (average)

  472. UNIPDi004-B (HDP04)

    Italy University of Padova (UNIPD)
    Disease:

    Normal (average)

  473. UOSe001-A (MasterShef1, MShef1 and MstrShef1)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  474. UOSe007-A (MstrShef2, MShef2 and MasterShef2)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  475. UOSe008-A (MstrShef3, MShef3 and MasterShef3)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  476. UOSe009-A (MstrShef4, MShef4 and MasterShef4)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  477. UOSe010-A (MstrShef5, MShef5 and MasterShef5)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  478. UOSe011-A (MstrShef6, MShef6 and MasterShef6)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  479. UOSe012-A (MstrShef7, MShef7 and MasterShef7)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  480. UOSe013-A (MstrShef8, MasterShef8 and MShef8)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  481. UOSe014-A (MasterShef10, MShef10 and MstrShef10)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  482. UOSe015-A (MasterShef11, MstrShef11 and MShef11)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  483. UOSe016-A (MasterShef12, MShef12 and MstrShef12)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  484. UOSe017-A (MasterShef13, MstrShef13 and MShef13)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  485. UOSe018-A (MasterShef14, MShef14 and MstrShef14)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal (average)

  486. UTHSCHi001-A (NDC-AD01)

    United States The University of Texas Health Science Center at Houston (UTHSCH)
    Disease:

    Alzheimer's disease

  487. VIACe001-A-1 (BG01V/hOG)

    United States Novocell, Inc. (VIAC)

  488. WAe001-A (WA01 and H1)

    United States WiCell Research Institute (WA)
    Disease:

    Normal (average)

  489. WAe007-A (H7 and WA07)

    United States WiCell Research Institute (WA)
    Disease:

    Normal (average)

  490. WAe009-A (WA09 and H9)

    United States WiCell Research Institute (WA)
    Disease:

    Normal (average)

  491. WAe013-A (WA13 and H13)

    United States WiCell Research Institute (WA)

  492. WAe014-A (WA14 and H14)

    United States WiCell Research Institute (WA)

  493. WIBRe001-A-2 (WIBR3 Oct4-2A-GFP)

    United States Whitehead Institute for Biomedical Research (WIBR)
    Disease:

    Normal (average)

  494. WIBRe004-A (WIN1 and Whitehead Institute Naive Human 1)

    United States Whitehead Institute for Biomedical Research (WIBR)
    Disease:

    Normal (average)

  495. WTSIi001-A (HPSI1213i-pahc_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  496. WTSIi037-A (HPSI0114i-zoxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  497. WTSIi038-A (HPSI1113i-ieki_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  498. WTSIi046-B (HPSI0214i-wibj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  499. WTSIi047-B (HPSI0814i-bokz_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  500. WTSIi049-A (HPSI0514i-wiii_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  501. WTSIi049-B (HPSI0514i-wiii_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  502. WTSIi052-A (HPSI1114i-ziyn_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  503. WTSIi053-A (HPSI0413i-corn_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  504. WTSIi054-B (HPSI0413i-nudd_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  505. WTSIi056-A (HPSI0513i-dipe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  506. WTSIi057-B (HPSI0513i-giuf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  507. WTSIi059-A (HPSI0513i-uilw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  508. WTSIi063-A (HPSI0613i-aevs_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  509. WTSIi068-B (HPSI0613i-giuo_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  510. WTSIi069-A (HPSI0613i-hegp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  511. WTSIi073-A (HPSI0314i-sojd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  512. WTSIi082-A (HPSI1013i-cups_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  513. WTSIi083-A (HPSI1213i-xuja_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  514. WTSIi085-A (HPSI1113i-eofe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  515. WTSIi086-A (HPSI0913i-coyi_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  516. WTSIi098-A (HPSI1213i-nekd_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  517. WTSIi102-A (HPSI0413i-iakz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  518. WTSIi102-B (HPSI0413i-iakz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  519. WTSIi103-A (HPSI1213i-nusw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  520. WTSIi104-A (HPSI0513i-coio_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  521. WTSIi104-B (HPSI0513i-coio_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  522. WTSIi105-A (HPSI0313i-airc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  523. WTSIi105-B (HPSI0313i-airc_66)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  524. WTSIi106-B (HPSI0613i-hikj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  525. WTSIi109-A (HPSI0413i-coxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  526. WTSIi109-B (HPSI0413i-coxy_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  527. WTSIi110-A (HPSI0713i-darw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  528. WTSIi111-A (HPSI0513i-euir_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  529. WTSIi112-A (HPSI0613i-funp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  530. WTSIi114-A (HPSI0513i-golb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  531. WTSIi115-A (HPSI0513i-iasn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  532. WTSIi116-A (HPSI0813i-iicq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  533. WTSIi117-A (HPSI0613i-liun_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  534. WTSIi118-A (HPSI0813i-meqo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  535. WTSIi119-A (HPSI0613i-oefg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  536. WTSIi120-A (HPSI0513i-oeoo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  537. WTSIi121-A (HPSI0413i-ougl_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  538. WTSIi121-B (HPSI0413i-ougl_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  539. WTSIi122-A (HPSI0413i-peop_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  540. WTSIi123-A (HPSI0713i-qimz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  541. WTSIi124-A (HPSI0713i-ruyv_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  542. WTSIi124-B (HPSI0713i-ruyv_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  543. WTSIi125-A (HPSI0413i-uahf_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  544. WTSIi126-A (HPSI0913i-vopm_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  545. WTSIi127-A (HPSI0413i-xekf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  546. WTSIi128-A (HPSI0413i-yuze_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  547. WTSIi129-A (HPSI0613i-zisa_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  548. WTSIi130-A (HPSI0713i-aehn_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  549. WTSIi131-A (HPSI0513i-aipt_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  550. WTSIi133-A (HPSI0713i-dard_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  551. WTSIi133-B (HPSI0713i-dard_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  552. WTSIi134-B (HPSI0513i-dulv_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  553. WTSIi137-A (HPSI0613i-lizq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  554. WTSIi137-B (HPSI0613i-lizq_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  555. WTSIi138-A (HPSI0414i-mita_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  556. WTSIi139-A (HPSI1113i-oaaz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  557. WTSIi140-A (HPSI0613i-oomz_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  558. WTSIi141-A (HPSI0613i-qanu_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  559. WTSIi142-A (HPSI0613i-qony_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  560. WTSIi144-A (HPSI0114i-wegi_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  561. WTSIi145-A (HPSI0813i-wots_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  562. WTSIi146-A (HPSI0613i-xosg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  563. WTSIi168-A (HPSI0214i-poih_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  564. WTSIi168-B (HPSI0214i-poih_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  565. WTSIi169-A (HPSI0614i-miaj_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  566. WTSIi170-B (HPSI1213i-tolg_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  567. WTSIi171-A (HPSI0914i-zerv_7)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  568. WTSIi171-B (HPSI0914i-zerv_8)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  569. WTSIi172-A (HPSI0914i-laey_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  570. WTSIi172-B (HPSI0914i-laey_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  571. WTSIi173-A (HPSI0414i-naju_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  572. WTSIi174-A (HPSI0614i-paab_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  573. WTSIi175-A (HPSI1014i-tixi_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  574. WTSIi176-B (HPSI0714i-iudw_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  575. WTSIi177-A (HPSI0414i-xojn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  576. WTSIi178-B (HPSI0215i-fawm_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  577. WTSIi179-A (HPSI0314i-wigw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  578. WTSIi180-A (HPSI0514i-puie_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  579. WTSIi180-B (HPSI0514i-puie_5)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  580. WTSIi181-A (HPSI0514i-rutc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  581. WTSIi182-A (HPSI0614i-kegd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  582. WTSIi183-A (HPSI0414i-oaqd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  583. WTSIi183-B (HPSI0414i-oaqd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  584. WTSIi184-A (HPSI1014i-qayj_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  585. WTSIi184-B (HPSI1014i-qayj_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  586. WTSIi186-A (HPSI1014i-babz_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  587. WTSIi187-A (HPSI1013i-sita_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  588. WTSIi188-A (HPSI1014i-kefb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  589. WTSIi189-A (HPSI1014i-quls_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  590. WTSIi190-A (HPSI0914i-kajh_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  591. WTSIi191-A (HPSI0215i-oilg_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal (average)

  592. XACHi004-A

    China Xi'an children's hospital (XACH)
    Disease:

    Atrial fibrillation

  593. XXMUFAi001-A

    China The First Affiliated Hospital of Xinxiang Medical University (XXMUFA)
    Disease:

    Long qt syndrome 2

  594. YBLi004-A (YBL/SH/2018/0062)

    India Yashraj Biotechnology ltd Navi Mumbai India (YBL)
    Disease:

    Normal (average)

  595. YBLi005-A (YBL/OS/2021/00196)

    India Yashraj Biotechnology ltd Navi Mumbai India (YBL)
    Disease:

    Normal (average)

  596. YBLi006-A (YBL/PH/2022/0025)

    India Yashraj Biotechnology ltd Navi Mumbai India (YBL)

  597. YUCMi020-A

    South Korea Yonsei University College of Medicine (YUCM)
    Disease:

    Normal (average)

  598. ZJSHi001-A (ZJSHi-KCNB1)

    China Department of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine (ZJSH)
    Disease:

    Developmental and epileptic encephalopathy, 26

  599. WAe009-A-B

    China Zhengzhou Central Hospital Affiliated (ZZCH)
    Disease:

    Heart failure

  600. ZZUNEUi010-A (CMF001-A)

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Juvenile amyotrophic lateral sclerosis

  601. ZZUNEUi026-A

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Hypertrophic cardiomyopathy

  602. WAe009-A-C

    China The Second Affiliated Hospital (ZZUSA)
    Disease:

    Heart failure